retatrutide fat loss results UK 2026: Phase 3 Retatrutide—A Game Changer in Obesity

Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial

Our semaglutide to tirzepatide conversion chart can help with the transition, and our semaglutide vs tirzepatide side effects comparison covers what to expect

A While the risk of hypoglycemia with Mounjaro is relatively low, if excessive dietary restrictions are implemented in parallel with Mounjaro use, symptoms of hypoglycemia such as dizziness, fatigue, and palpitations may occur

and Metabolism 88 (10), 46964701

What will the next five years look like

In the SURPASS-4 trial, adults with T2DM at heightened cardiovascular risk, who were inadequately managed with oral glucose-lowering agents, once-weekly tirzepatide (5 mg, 10 mg, or 15 mg) were compared to insulin glargine (100 U/mL)